Protocol Ledger

Academic / Institutional Sponsor · Consolidated Sponsor Hub

Sunnybrook Health Sciences Centre: Clinical Trials & FDA Approval Profile

Sunnybrook Health Sciences Centre (Global / Institutional) sponsors 48 reconciled interventional Phase II and Phase III ClinicalTrials.gov studies (2018 to 2026), including 26 active protocols (20 recruiting now), 10 completed protocols, and 0 all-time original FDA Drugs@FDA NDA and BLA approvals.

Primary Focus: Oncology and Hematology Interactive Workbench: Open Full Annual Timeline & Compare ->
Track in Studio / Generate Client Brief ->
Early-Stop Rate vs National (13.8%)12.5%
Median Closed Enrollment vs National (145 pts)51 participants

Verified Sponsor Execution & Regulatory Ledger

Reconciled ClinicalTrials.gov v2 & Drugs@FDA Metrics for Sunnybrook Health Sciences Centre
Sponsor MetricVerified Count / Rate
Phase II & III Protocols (2018 to 2026)48
Active Pipeline (Recruiting Now)26 (20)
Completed vs Stopped Early10 / 6 (12.5%)
Median Closed Actual Enrollment51 participants
Physical Hospital Site Disclosure100.0% named hospitals
FDA Drugs@FDA Original NDA/BLA Approvals0 (0 since 2018)

Top Partner U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Partnered With Sunnybrook Health Sciences Centre
Hospital Research SiteLocationShared Protocols
Sunnybrook Health Sciences CentreToronto, Ontario31
The Ottawa HospitalOttawa, Ontario7
London Health Sciences CentreLondon, Ontario4

Indexed Multi-Center Phase II & III Protocols

Representative ClinicalTrials.gov v2 Studies Sponsored by Sunnybrook Health Sciences Centre
NCT IdentifierProtocol Brief TitlePhaseStatus
NCT03559114PROphylaxis for Venous ThromboEmbolism in Severe Traumatic Brain Injury (PROTEST)Phase IIIRECRUITING

Explore interactive annual charts and M&A subsidiary rollups in the Sunnybrook Health Sciences Centre Interactive Dossier, benchmark peers in Oncology and Hematology, or review the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI